Biology subjects

Pronier, E.

Publications and source records attributed to Pronier, E..

7 recordsLinked to original sources

bioRxiv2026

Identification of non-covalent inhibitors for the atypical peroxiredoxin PRDX5 as a therapeutic strategy in malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is an aggressive asbestos-linked cancer with limited therapeutic options and a dismal 5-year survival rate of [~]5%. While aberrant production of reactive oxygen and nitrogen species (ROS/RNS) is a hallmark of MPM, targeted approaches to exploit these redox vulnerabilities remain scarce. Here, using the MOSAIC multimodal cancer patient atlas, we identify Peroxiredoxin 5 (PRDX5) as being significantly upregulated in the epithelioid subtype of MPM. We show that MPM cells exhibit enhanced resistance to nitrosative and oxidative stress compared to healthy mesothelial cells, a phenotype correlated with basal PRDX5 expression. Next, utilising a machine learning guided discovery pipeline, we identified three putative allosteric pockets in PRDX5 and conducted a virtual screen of 3.6 million compounds. High-throughput biochemical validation of 452 candidates yielded 36 non-covalent hits, including sub-micromolar inhibitors. These findings establish PRDX5 as a novel, subtype specific therapeutic target in MPM and provide a chemical framework for the development of next-generation redox-modulating oncology treatments.

cancer biology↗

bioRxiv2025

Deciphering Cellular Ecosystems Driving Tumor Progression and Immune Escape from Spatial Transcriptomics and Single-Cell with COMPOTES

Cell-cell communication is central to understanding the complex interactions within the tumor microenvironment. However, current methods fail to identify recurrent communication patterns across patient cohorts from spatial transcriptomics, as they are often limited to single samples or lack essential spatial context. Yet this is essential for understanding how local environments influence cell phenotype and states, and shape the entire cellular ecosystem. We introduce a machine-learning approach that models local, spatially aware ligand-receptor interactions and uses matrix factorization to extract global multicellular programs from large cohorts representing the complex biology of cancer. Applied to a multimodal muscle-invasive bladder cancer cohort of 146 patients, it uncovered 45 communication programs defined by distinct ligand-receptor pairs and cellular niches. In particular, we identified a conserved immune program linked to stalled anti-tumor immunity and a program linking KMT2D loss-of-function mutations with early-stage (T2) tumors, intense proliferation and a favorable response to neoadjuvant chemotherapy.

bioinformatics↗

bioRxiv2025

Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma

BackgroundGlioblastoma (GBM), the most aggressive primary brain tumor, has a median survival of approximately 15 months. Twenty percent of patients survive beyond three years, but known clinical factors like age, performance status, resection extent, and MGMT promoter methylation status do not fully explain the observed outcomes. ObjectiveOur objective was to identify novel histology derived biomarkers associated with end-of-spectrum overall survival (OS) to provide novel biological insight with a translational potential. MethodsWe analyzed a total of 748 GBM patients from 3 different cohorts, uniquely enriched in long survivors (n=98 with overall survival (OS) > 5y including n=196 with OS[≥]3y), with clinical data and H&E slides obtained from the primary tumor at baseline. We propose an interpretable machine learning (ML) methodology for the discovery of histological biomarkers. Our method learned to segment each H&E slide into three distinct regions associated with long-term survival, short-term survival, and non-informative tissue. We characterized these regions by integrating unsupervised learning, nuclei segmentation, blood vessels detection, pathologist annotations, and multimodal data including spatial transcriptomics from n=31 patients of the GBM MOSAIC dataset to discover fully interpretable biomarkers. ResultsOur OS prediction model using histology and clinical data as input achieved an area under the curve (AUC) of 0.85 for the classification of patients between OS<2 and OS[≥]3y in external cohort validation, outperforming significantly models trained on clinical data or on histology alone (AUC of 0.76; 0.73, respectively). Two novel biomarkers were predicting poor survival: the presence of regions of lowly infiltrated white matter enriched in malignant cells with a mesenchymal-like phenotype, and lower levels of angiogenesis associated with higher hypoxia response in the main tumor regions. We also found that a subtype of immunosuppressive tumor macrophages - defined by high PLIN2 expression and lipid accumulation- is consistently enriched in histological areas predictive of poor prognosis. ConclusionOur interpretable ML methodology identified a novel prognostic impact of biological processes and cell types according to distinct tumor regions of GBM. These results pave the way for spatially-informed biomarkers to improve risk stratification and for personalized spatially-targeted therapeutic strategies. Key highlightsO_LIOur ML model identified histological biomarkers predicting prognosis independently from known clinical factors C_LIO_LIThe region of lowly infiltrated white matter enriched in malignant cells including a mesenchymal-like phenotype is predictive of poor prognosis C_LIO_LIAngiogenesis is increased in areas predictive of long survival in main non-necrotic tumor regions. C_LIO_LIThe subtype of macrophages expressing PLIN2 and associated with increased lipid metabolism was associated with poor prognosis in all GBM regions. C_LI Highlights O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=116 SRC="FIGDIR/small/681087v4_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@45e619org.highwire.dtl.DTLVardef@105a4b0org.highwire.dtl.DTLVardef@17f257dorg.highwire.dtl.DTLVardef@7669b4_HPS_FORMAT_FIGEXP M_FIG C_FIG

cancer biology↗

bioRxiv2024

A deep learning-based multiscale integration of spatial omics with tumor morphology.

Spatial Transcriptomics (spTx) offers unprecedented insights into the spatial arrangement of the tumor microenvironment, tumor initiation/progression and identification of new therapeutic target candidates. However, spTx remains complex and unlikely to be routinely used in the near future. Hematoxylin and eosin (H&E) stained histological slides, on the other hand, are routinely generated for a large fraction of cancer patients. Here, we present a novel deep learning-based approach for multiscale integration of spTx with tumor morphology (MISO). We trained MISO to predict spTx from H&E on a new unpublished dataset of 72 10X Genomics Visium samples, and derived a novel estimate of the upper bound on the achievable performance. We demonstrate that MISO enables near single-cell-resolution, spatially-resolved gene expression prediction from H&E. In addition, MISO provides an effective patient representation framework that enables downstream predictive tasks such as molecular phenotyping or MSI prediction.

bioinformatics↗

bioRxiv2024

Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients.

Over the last decade, Hippo signaling has emerged as a major tumor-suppressing pathway. Its dysregulation is associated with abnormal expression of YAP1 and TEAD-family genes. Recent works have highlighted the role of YAP1/TEAD activity in several cancers and its potential therapeutic implications. Therefore, identifying patients with a dysregulated Hippo pathway is key to enhancing treatment impact. Although recent studies have derived RNAseq-based signatures, there remains a need for a reproducible and cost-effective method to measure the pathway activation. In recent years, deep learning applied to histology slides have emerged as an effective way to predict molecular information from a data modality available in clinical routine. Here, we trained models to predict YAP1/TEAD activity from H&E-stained histology slides in multiple cancers. The robustness of our approach was assessed in seven independent validation cohorts. Finally, we showed that histological markers of disease aggressiveness were associated with dysfunctional Hippo signaling.

bioinformatics↗

bioRxiv2024

Dorso-ventral hippocampal neural assemblies are preferentially reactivated during NREM sleep following an aversive experience

The integration of spatial and emotional components into episodic memory relies on coordinated interactions between hippocampal circuits and emotion-processing regions. While the dorsal hippocampus (dHPC) supports memory consolidation through sharp-wave ripple (SWR)-associated reactivation of spatial representations, it lacks direct connectivity with key emotional centers such as the amygdala. In contrast, the ventral hippocampus (vHPC) is anatomically and functionally embedded within the emotional network. How the dHPC and vHPC coordinate during sleep to support the processing of complex contextual and emotional experiences remains unclear. Here, we used simultaneous electrophysiological recordings from the dHPC and vHPC in rats performing a spatial alternation task under opposite emotional valence and during subsequent sleep. We show that dorso-ventral neuronal assemblies better disambiguate the between valence than isolated dorsal or ventral assemblies. During non-REM sleep, coordinated SWRs orchestrate assembly reactivation across the dorso-ventral hippocampal axis following both aversive and rewarding experiences; however, reactivation after aversive trials more closely mirrors the original neural patterns. This enhanced fidelity is driven by the heightened recruitment of shock-responsive neurons of the ventral hippocampus and spatial replay of the dorsal hippocampus into coordinated SWRs. Our findings identify a mechanism by which the hippocampus integrates the spatial and emotional dimensions of an experience during sleep, potentially routing information to the broader emotional memory network via synchronized SWRs.

neuroscience↗

bioRxiv2019

Transcriptomic learning for digital pathology

Deep learning methods for digital pathology analysis have proved an effective way to address multiple clinical questions, from diagnosis to prognosis and even to prediction of treatment outcomes. They have also recently been used to predict gene mutations from pathology images, but no comprehensive evaluation of their potential for extracting molecular features from histology slides has yet been performed. We propose a novel approach based on the integration of multiple data modes, and show that our deep learning model, HE2RNA, can be trained to systematically predict RNA-Seq profiles from whole-slide images alone, without the need for expert annotation. HE2RNA is interpretable by design, opening up new opportunities for virtual staining. In fact, it provides virtual spatialization of gene expression, as validated by double-staining on an independent dataset. Moreover, the transcriptomic representation learned by HE2RNA can be transferred to improve predictive performance for other tasks, particularly for small datasets. As an example of a task with direct clinical impact, we studied the prediction of microsatellite instability from hematoxylin & eosin stained images and our results show that better performance can be achieved in this setting.

bioinformatics↗